SeaStar Medical Holding Corporation Share Price
ICUSeaStar Medical Holding Corporation Stock Performance
Open $2.45 | Prev. Close $2.45 | Circuit Range N/A |
Day Range $2.43 - $2.49 | Year Range $0.22 - $2.94 | Volume 1,773 |
Average Traded $2.47 |
SeaStar Medical Holding Corporation Share Price Chart
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
SeaStar Medical Holding Corporation Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $2.45 | $2.49 | -5.50% |
04-Feb-26 | $2.53 | $2.63 | +3.54% |
02-Feb-26 | $2.40 | $2.54 | +6.93% |
30-Jan-26 | $2.32 | $2.38 | +3.70% |
29-Jan-26 | $2.31 | $2.29 | -6.71% |
27-Jan-26 | $2.46 | $2.46 | -0.81% |
26-Jan-26 | $2.55 | $2.48 | -6.06% |